v3.26.1
Stockholders' Deficiency (Tables)
9 Months Ended
Mar. 31, 2026
Stockholders' Deficiency [Abstract]  
Schedule of Warrants Outstanding

Warrants outstanding as of March 31, 2026 are as follows:

 

   Shares   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
Term (Years)
 
Outstanding at June 30, 2024   1   $357,140    3.1 
Granted   13,034    90    2.6 
Adjustment*   19,961    (55.8)     
Exercised   (9,812)   38.6    - 
Outstanding at June 30, 2025   23,184    34.2    2.3 
Granted   363,732    6.7    1.8 
Adjustment*   389,947    (3.2)     
Exercised   (299,323)   5.6      
Outstanding at March 31, 2026 (Unaudited)   477,540   $5.1    1.6 

 

*Adjustment reflects the change in the number of shares issuable under the Purchase Warrant issued to Alumni Capital due to the contractual pricing mechanism based on outstanding shares. Upon any such price-based adjustment to the exercise price, the number of shares issuable upon exercise of the warrants will be adjusted proportionally
Schedule of Restricted Stock Award Activity

The Company’s Restricted Stock Award activity for the nine months ended March 31, 2026 was as follows:

 

   Shares   Weighted
Average
Grant Date
Fair Value
per Share
 
Outstanding as of June 30, 2025   
-
   $
 
Granted   36,279    17.69 
Vested   (26,083)   18.28 
Forfeited   
-
    
 
Outstanding as of March 31, 2026 (Unaudited)   10,196   $16.18